University of Malaya Medical Centre, formerly known as University Hospital, is a government-funded medical institution located in Pantai Dalam, southwest corner of Kuala Lumpur, Malaysia. It was established by Statute in September 1962 and is part of University of Malaya.

There are 1,617 beds in University Malaya Medical Centre.

During the past decade, University Malaya Medical Centre conducted 191 clinical trials. In the 10-year time frame, 191 clinical trials started and 53 clinical trials were completed, i.e. on average, 27.7% percent of trials that started reached the finish line to date. In the past 5 years, 108 clinical trials started and 38 clinical trials were completed. i.e. 35.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Malaya Medical Centre" #1 sponsor was "University of Malaya" with 66 trials, followed by "Janssen Research & Development, LLC" with 25 trials sponsored, "Boehringer Ingelheim" with 14 trials sponsored, "Pfizer" with 9 trials sponsored and "Albireo" with 9 trials sponsored. Other sponsors include 134 different institutions and companies that sponsored additional 100 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Malaya Medical Centre" #1 collaborator was "University of Malaya" with 8 trials as a collaborator, "Gilead Sciences" with 5 trials as a collaborator, "Merck Sharp & Dohme LLC" with 5 trials as a collaborator, "National Health and Medical Research Council, Australia" with 5 trials as a collaborator and "National University Hospital, Singapore" with 4 trials as a collaborator. Other collaborators include 160 different institutions and companies that were collaborators in the rest 143 trials.

According to Clinical.Site data, the most researched conditions in "University Malaya Medical Centre" are "Carcinoma, Non-Small-Cell Lung" (5 trials), "Critical Illness" (5 trials), "Crohn's Disease" (5 trials), "Depressive Disorder, Major" (5 trials) and "Schizophrenia" (5 trials). Many other conditions were trialed in "University Malaya Medical Centre" in a lesser frequency.

Most popular intervention types in "University Malaya Medical Centre" are "Drug" (170 trials), "Other" (45 trials), "Device" (26 trials), "Procedure" (12 trials) and "Biological" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (58 trials), "Carboplatin" (9 trials), "Pemetrexed" (6 trials), "Amivantamab" (5 trials) and "Cisplatin" (5 trials). Other intervention names were less common.

The vast majority of trials in "University Malaya Medical Centre" are 234 trials for "All" genders, 16 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 91 active trials in "University Malaya Medical Centre". 2 are not yet recruiting, 57 are recruiting, 29 are Active, not recruiting, and 3 are Enrolling by invitation. In total, there were 115 completed trials in University Malaya Medical Centre, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in University Malaya Medical Centre, 8 "Phase 1" clinical trials were conducted, 44 "Phase 2" clinical trials and 95 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 29 trials, and there were also 56 trials that are defined as “Not Applicable".

University Malaya Medical Centre has several departments that took part in Clinical trials: "University Malaya Medical Centre; Clinical Oncology Unit," - 6 trials